TY - JOUR TI - Risk of second primary malignancies in women with breast cancer: Results from the European prospective investigation into cancer and nutrition (EPIC) AU - Ricceri, Fulvio AU - Fasanelli, Francesca AU - Giraudo, Maria Teresa and AU - Sieri, Sabina AU - Tumino, Rosario AU - Mattiello, Amalia AU - Vagliano, AU - Liliana AU - Masala, Giovanna AU - Ramon Quiros, J. AU - Travier, Noemie AU - and Sanchez, Maria-Jose AU - Larranaga, Nerea AU - Chirlaque, AU - Maria-Dolores AU - Ardanaz, Eva AU - Tjonneland, Anne AU - Olsen, Anja and AU - Overvad, Kim AU - Chang-Claude, Jenny AU - Kaaks, Rudolf AU - Boeing, AU - Heiner AU - Clavel-Chapelon, Franc Oise AU - Kvaskoff, Marina AU - Dossus, AU - Laure AU - Trichopoulou, Antonia AU - Benetou, Vassiliki AU - Adarakis, AU - George AU - Bueno-de-Mesquita, H. B(As) AU - Peeters, Petra H. AU - Sund, AU - Malin AU - Andersson, Anne AU - Borgquist, Signe AU - Butt, Salma and AU - Weiderpass, Elisabete AU - Skeie, Guri AU - Khaw, Kay-Tee AU - Travis, Ruth AU - C. AU - Rinaldi, Sabina AU - Romieu, Isabelle AU - Gunter, Marc AU - Kadi, AU - Mai AU - Riboli, Elio AU - Vineis, Paolo AU - Sacerdote, Carlotta JO - International Journal of Cancer PY - 2015 VL - 137 TODO - 4 SP - 940-948 PB - Wiley SN - 0020-7136 TODO - 10.1002/ijc.29462 TODO - second primary tumours; breast cancer; Aalen-Johansen estimator; tumour size TODO - Women with a diagnosis of breast cancer are at increased risk of second primary cancers, and the identification of risk factors for the latter may have clinical implications. We have followed-up for 11 years 10,045 women with invasive breast cancer from a European cohort, and identified 492 second primary cancers, including 140 contralateral breast cancers. Expected and observed cases and Standardized Incidence Ratios (SIR) were estimated using Aalen-Johansen Markovian methods. Information on various risk factors was obtained from detailed questionnaires and anthropometric measurements. Cox proportional hazards regression models were used to estimate the role of risk factors. Women with breast cancer had a 30% excess risk for second malignancies (95% confidence interval-CI 18-42) after excluding contralateral breast cancers. Risk was particularly elevated for colorectal cancer (SIR, 1.71, 95% CI 1.43-2.00), lymphoma (SIR 1.80, 95% CI 1.31-2.40), melanoma (2.12; 1.63-2.70), endometrium (2.18; 1.75-2.70) and kidney cancers (2.40; 1.57-3.52). Risk of second malignancies was positively associated with age at first cancer, body mass index and smoking status, while it was inversely associated with education, post-menopausal status and a history of full-term pregnancy. We describe in a large cohort of women with breast cancer a 30% excess of second primaries. Among risk factors for breast cancer, a history of full-term pregnancy was inversely associated with the risk of second primary cancer. What’s new? For the first time, researchers have used cohort data to show that people who survive breast cancer have a higher risk of developing another cancer later. By collecting data on 10,000 breast cancer patients over 11 years, these authors calculated a 30% boost in the patients’ risk of developing a second primary malignancy, particularly colorectal cancer, lymphoma, melanoma, endometrial cancer, and kidney cancer. These findings, plus the data they collected on risk factors such as age, smoking, body mass index, and others, will help guide clinicians in screening procedures and follow up care for breast cancer patients. ER -